Article
Gene expression profiling of peritoneal metastases from appendiceal and colon cancer demonstrates unique biologic signatures and predicts patient outcomes.
Journal of the American College of Surgeons - 1 Apr 2012
Levine Edward A, Blazer Dan G, Kim Mickey K, Shen Perry, Stewart John H, Guy Cynthia, Hsu David S
Abstract excerpt
BACKGROUND: Treatment of peritoneal metastases from appendiceal and colon cancer with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) shows great promise. Although long-term disease-free survival is achieved in some cases with this procedure, many patients have recurrence. Oncologists have treated such recurrences of appendiceal cancer similarly to colorectal carcinoma, which has been...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
